Infliximab-induced psoriasis in a patient with crohn′s disease
Infliximab is a well-known treatment for inflammatory bowel diseases (IBDs) and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-α antagonist therapy in patients with IBD. Here, we report a case with Crohn′s disease who developed Infli...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Series: | Saudi Journal of Medicine and Medical Sciences |
| Subjects: | |
| Online Access: | http://www.sjmms.net/article.asp?issn=1658-631X;year=2015;volume=3;issue=1;spage=81;epage=83;aulast=Bukhari |
| _version_ | 1828498830585233408 |
|---|---|
| author | Iqbal Bukhari Nasser Alzoubi Abdulaziz A Al-Quorain |
| author_facet | Iqbal Bukhari Nasser Alzoubi Abdulaziz A Al-Quorain |
| author_sort | Iqbal Bukhari |
| collection | DOAJ |
| description | Infliximab is a well-known treatment for inflammatory bowel diseases (IBDs) and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-α antagonist therapy in patients with IBD. Here, we report a case with Crohn′s disease who developed Infliximab-induced plaque-type psoriasis 4 months after initiation of treatment with Infliximab. |
| first_indexed | 2024-12-11T13:14:21Z |
| format | Article |
| id | doaj.art-9c2d231de80d40818c0a5a017378460c |
| institution | Directory Open Access Journal |
| issn | 1658-631X |
| language | English |
| last_indexed | 2024-12-11T13:14:21Z |
| publishDate | 2015-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Saudi Journal of Medicine and Medical Sciences |
| spelling | doaj.art-9c2d231de80d40818c0a5a017378460c2022-12-22T01:06:06ZengWolters Kluwer Medknow PublicationsSaudi Journal of Medicine and Medical Sciences1658-631X2015-01-0131818310.4103/1658-631X.149695Infliximab-induced psoriasis in a patient with crohn′s diseaseIqbal BukhariNasser AlzoubiAbdulaziz A Al-QuorainInfliximab is a well-known treatment for inflammatory bowel diseases (IBDs) and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-α antagonist therapy in patients with IBD. Here, we report a case with Crohn′s disease who developed Infliximab-induced plaque-type psoriasis 4 months after initiation of treatment with Infliximab.http://www.sjmms.net/article.asp?issn=1658-631X;year=2015;volume=3;issue=1;spage=81;epage=83;aulast=BukhariBiological therapyCrohn′s diseaseInfliximabpsoriasistumor necrosis factor-alpha inhibitors |
| spellingShingle | Iqbal Bukhari Nasser Alzoubi Abdulaziz A Al-Quorain Infliximab-induced psoriasis in a patient with crohn′s disease Saudi Journal of Medicine and Medical Sciences Biological therapy Crohn′s disease Infliximab psoriasis tumor necrosis factor-alpha inhibitors |
| title | Infliximab-induced psoriasis in a patient with crohn′s disease |
| title_full | Infliximab-induced psoriasis in a patient with crohn′s disease |
| title_fullStr | Infliximab-induced psoriasis in a patient with crohn′s disease |
| title_full_unstemmed | Infliximab-induced psoriasis in a patient with crohn′s disease |
| title_short | Infliximab-induced psoriasis in a patient with crohn′s disease |
| title_sort | infliximab induced psoriasis in a patient with crohn s disease |
| topic | Biological therapy Crohn′s disease Infliximab psoriasis tumor necrosis factor-alpha inhibitors |
| url | http://www.sjmms.net/article.asp?issn=1658-631X;year=2015;volume=3;issue=1;spage=81;epage=83;aulast=Bukhari |
| work_keys_str_mv | AT iqbalbukhari infliximabinducedpsoriasisinapatientwithcrohnsdisease AT nasseralzoubi infliximabinducedpsoriasisinapatientwithcrohnsdisease AT abdulazizaalquorain infliximabinducedpsoriasisinapatientwithcrohnsdisease |